home

research and development

transmucosal drug delivery

development status
technology

 
  Transmucosal Drug Delivery (OraDisc™)  
  Development Status:  
     
 

Mucoadhesive film product containing amlexanox for the treatment of aphthous ulcers has received FDA approval.

 
     
 
  • Product tested in 1,200 patients.
  • 2 placebo controlled efficacy studies.
  • 28 days safety testing.
  • Irritation study.
  • 2 year ICH stability testing.
  • Manufacturing scale-up to 10% of commercial production.
  • Commercial packaging initiated.
 
 

Mucoadhesive film product containing benzocaine for the treatment of oral pain developed in conjunction with a major pharmaceutical company, ready for production validation.

 
     
 

Prototype products for oral and systemic applications developed for:

 
 

 

 
 
  • Oxandrolone

  • Cough suppressant

  • Sore throat treatment

  • Long-acting breath freshener

 
  Prototype dental products developed for:  
     
 
  • Erodible tooth whitening strip
  • De-sensitizing strip
  • Fluoride strip
  • Remineralization strip
  • Disc to reduce salivation
 
     

 

 

© 2011 ULURU Inc.

Latest News
ULURU Inc. developed and commercializes Altrazeal®, a transforming powder dressing with proprietary Nanoflex® technology, for the management of exuding wounds.
Visit
www.altrazeal.com
for clinical case studies, patient testimonials, application guidelines, and much more…